Health and Medical Research News
Jasmine C
Health and Medical Research News
Proton Pump Inhibitors Linked to Increased Risk of Kidney Stones
What Did the Research Discover? This study investigated the association between proton pump inhibitor (PPI) use and kidney stone risk in U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2018. PPIs, commonly prescribed for acid-related conditions such as gastroesophageal reflux disease
2024 Approvals
Xolremdi: A New Treatment for WHIM Syndrome Approved on April 26, 2024
What is it prescribed for? XOLREMDI is indicated in patients 12 years of age and older with WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis) to increase the number of circulating mature neutrophils and lymphocytes. What is the name of the drug and what does it do? Xolremdi (pronounced zohl-REM-dee), (generic
Health and Medical Research News
Could Parkinson's Disease Risk Be Lowed By Diabetes Drugs
What Did the Research Discover? Researchers conducted a meta-analysis of 24 randomized placebo-controlled trials to determine if newer glucose-lowering drugs (GLDs), including DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors, are associated with a lower risk of Parkinson’s disease (PD). The study analyzed 185,305 participants over a median
2024 Approvals
Yorvipath: Managing Hypoparathyroidism with Ease Approved on August 9, 2024
What is the name of the drug and what does it do? Yorvipath (pronounced YOR-vih-path), generic name palopegteriparatide, is a medication used to treat adults with hypoparathyroidism, a condition where the parathyroid glands don’t produce enough parathyroid hormone (PTH). This hormone is essential for regulating calcium and phosphate levels
Health and Medical Research News
Can Treating High Blood Pressure Lower Your Risk of Alzheimer's Disease?
What Did the Research Discover? Researchers investigated whether high blood pressure (hypertension) and the use of antihypertensive medications affect the risk of developing Alzheimer’s disease (AD) and other types of dementia in older adults. This study combined data from 31,250 participants across 14 countries, with an average starting
Diabetes
Can a New Weight Loss Medication Help You Keep the Pounds Off?
What Did the Research Discover? Scientists conducted a study to see if a medication called tirzepatide could help people maintain and further their weight loss after an intensive diet and exercise program. The study included 579 adults who were overweight or obese but did not have diabetes. Before starting the
Health and Medical Research News
Primary Care Boosts Hepatitis C Treatment Rates
What Did the Research Discover? The research demonstrated that a 10-month quality improvement initiative significantly increased the number of Hepatitis C Virus (HCV) RNA-positive patients who initiated curative treatment in a primary care setting. The proportion of patients who started treatment rose from 66.0% to 75.5%, and of
Diabetes
Night Owls May Face Higher Diabetes Risk
What Did the Research Discover? This study explored the relationship between chronotype (morning vs. evening preference) and the risk of developing type 2 diabetes in middle-aged nurses. The findings suggest that nurses with an evening chronotype—those who naturally stay up late and wake up later—are more likely to
Diabetes
Reversing Prediabetes Dramatically Cuts Diabetes Risk
What Did the Research Discover? This study investigated whether lifestyle interventions (LI) for preventing type 2 diabetes are equally effective for all individuals with prediabetes or if different approaches are needed based on individual risk levels. The researchers categorized participants into low-risk (LR) and high-risk (HR) phenotypes based on factors
Health and Medical Research News
Are Night Owls at Higher Risk for Diabetes?
Do your natural sleep habits affect your risk of type 2 diabetes? A 2023 study published in Annals of Internal Medicine followed over 63,000 middle-aged nurses to explore whether being a night owl or morning person impacts diabetes risk—even after accounting for diet, weight, and lifestyle.
2025 Approvals
BLUJEPA(gepotidacin): FDA Approves New Treatment for Uncomplicated Urinary Tract Infections on March 25, 2025
What is it prescribed for? BLUJEPA is prescribed for the treatment of female adults and pediatric patients 12 years of age and older (weighing at least 40 kilograms, or 88 pounds) with uncomplicated urinary tract infections (uUTIs) caused by certain bacteria, including Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus